Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream [9]

Acta Dermato-Venereologica

Volumn 82, Issue 6, 2002, Pages 477-

  Oster Schmidt, C ^a   Altmeyer, Peter ^a   Stücker, Markus ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; BASAL CELL CARCINOMA; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; CREAM; DRUG EFFICACY; DRUG MECHANISM; EXCISION; FACE CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0036966244     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155502762064719     Document Type: Letter

References (5)

1. Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002-1007.
2. Cornell RC, Greenway HT, Tucher SB, et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23: 694-700.
3. Esser P, Konen W. Therapie von Basaliomen der Lidregion. Dt Ärztebl 2000; 97: A35-38.
4. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001; 44: 807-813.
5. Slade HB, Owens ML, Tomai MA, Miller RL. Imiquimod 5% cream (Aldara). Exp Opin Invest Drugs 2000; 7: 437-449.